| 000 | 01095 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514000853.0 | ||
| 264 | 0 | _c19950724 | |
| 008 | 199507s 0 0 eng d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGlick, M E | |
| 245 | 0 | 0 |
_aCTG studies yield results. AIDS Clinical Trials Group. _h[electronic resource] |
| 260 |
_bNIAID AIDS agenda _c1995 |
||
| 300 |
_a8-9 p. _bdigital |
||
| 500 | _aPublication Type: Newspaper Article; Journal Article | ||
| 650 | 0 | 4 |
_aAcyclovir _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xcomplications |
| 650 | 0 | 4 |
_aDidanosine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFluconazole _xtherapeutic use |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMycoses _xcomplications |
| 650 | 0 | 4 |
_aPneumonia, Pneumocystis _xcomplications |
| 650 | 0 | 4 | _aValacyclovir |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aZidovudine _xadministration & dosage |
| 773 | 0 |
_tNIAID AIDS agenda _gp. 8-9 |
|
| 999 |
_c11294458 _d11294458 |
||